Maravai LifeSciences Holdings, Inc. Interest Expense
Maravai LifeSciences Holdings, Inc. (MRVI) reported Interest Expense of $13.63 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-11-12
- Maravai LifeSciences Holdings, Inc. interest expense for the quarter ending 2024-09-30 was $13.63M, a 17.16% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense for the quarter ending 2024-06-30 was $11.94M, a 70.02% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense for the quarter ending 2024-03-31 was $10.86M, a 8.19% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense for the quarter ending 2023-12-31 was $15.40M, a 51.28% increase year-over-year.
- Maravai LifeSciences Holdings, Inc. interest expense for fiscal 2023 was $45.89M, a 124.81% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. interest expense for fiscal 2022 was $20.41M, a 32.54% decline from fiscal 2021.
- Maravai LifeSciences Holdings, Inc. interest expense for fiscal 2021 was $30.26M, a 1.56% decline from fiscal 2020.
- Maravai LifeSciences Holdings, Inc. interest expense for fiscal 2020 was $30.74M, a 2.61% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | $13.63M 10-Q · filed 2024-11-12 | $25.57M derived: sum of 2 quarters · filed 2024-11-12 | $36.44M 10-Q · filed 2024-11-12 | $51.84M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2024-06-30 | $11.94M 10-Q · filed 2024-08-08 | $22.80M 10-Q · filed 2024-08-08 | $38.20M derived: sum of 3 quarters · filed 2024-08-08 | $49.84M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2024-03-31 | $10.86M 10-Q · filed 2024-05-09 | $26.26M derived: sum of 2 quarters · filed 2024-05-09 | $37.90M derived: sum of 3 quarters · filed 2024-11-12 | $44.92M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-12-31 | $15.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $27.04M derived: sum of 2 quarters · filed 2024-11-12 | $34.06M derived: sum of 3 quarters · filed 2024-11-12 | $45.89M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $11.64M 10-Q · filed 2024-11-12 | $18.66M derived: sum of 2 quarters · filed 2024-11-12 | $30.49M 10-Q · filed 2024-11-12 | $40.67M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $7.02M 10-Q · filed 2024-08-08 | $18.86M 10-Q · filed 2024-08-08 | $29.04M derived: sum of 3 quarters · filed 2024-08-08 | $32.17M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $11.83M 10-Q · filed 2024-05-09 | $22.01M derived: sum of 2 quarters · filed 2024-05-09 | $25.15M derived: sum of 3 quarters · filed 2024-05-09 | $29.58M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $13.32M derived: sum of 2 quarters · filed 2024-02-29 | $17.75M derived: sum of 3 quarters · filed 2024-02-29 | $20.41M 10-K · filed 2024-02-29 | |||
| 2022-09-30 | $3.14M 10-Q · filed 2023-11-08 | $7.57M derived: sum of 2 quarters · filed 2023-11-08 | $10.23M 10-Q · filed 2023-11-08 | $17.26M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $4.43M 10-Q · filed 2023-08-08 | $7.10M 10-Q · filed 2023-08-08 | $14.12M derived: sum of 3 quarters · filed 2024-02-29 | $21.80M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $2.66M 10-Q · filed 2023-05-09 | $9.69M derived: sum of 2 quarters · filed 2024-02-29 | $17.37M derived: sum of 3 quarters · filed 2024-02-29 | $25.02M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $14.71M derived: sum of 2 quarters · filed 2024-02-29 | $22.36M derived: sum of 3 quarters · filed 2024-02-29 | $30.26M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $7.68M 10-Q · filed 2022-11-04 | $8.54M 10-Q · filed 2021-11-15 | $15.33M derived: sum of 2 quarters · filed 2022-11-04 | $23.24M 10-Q · filed 2022-11-04 | $25.83M 10-Q · filed 2021-11-15 | $32.04M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $7.65M 10-Q · filed 2022-08-05 | $8.51M 10-Q · filed 2021-08-11 | $15.55M 10-Q · filed 2022-08-05 | $17.28M 10-Q · filed 2021-08-11 | $24.36M derived: sum of 3 quarters · filed 2023-02-28 | $31.45M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | $7.90M 10-Q · filed 2022-05-06 | $8.77M 10-Q · filed 2021-05-12 | $16.71M derived: sum of 2 quarters · filed 2023-02-28 | $23.80M derived: sum of 3 quarters · filed 2023-02-28 | $31.26M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $15.89M derived: sum of 2 quarters · filed 2023-02-28 | $23.36M derived: sum of 3 quarters · filed 2023-02-28 | $30.74M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $7.09M 10-Q · filed 2021-11-15 | $14.55M derived: sum of 2 quarters · filed 2021-11-15 | $21.93M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $7.46M 10-Q · filed 2021-08-11 | $14.85M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $7.38M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $29.96M 10-K · filed 2022-03-01 |